Qiming et al to Fund RNAi Therapy
04 Dec 2023
US$ 19.00
Qiming Venture Partners and K2 Venture Partners, existing investors of Suzhou Sanegene Bio Inc (Sanegene), have made a...
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Investments (Subscribers' Weekly 06 Jun 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.